...
首页> 外文期刊>Clinical and experimental allergy >UK consensus statement on the diagnosis of inducible laryngeal obstruction in light of the COVID‐19 pandemic
【24h】

UK consensus statement on the diagnosis of inducible laryngeal obstruction in light of the COVID‐19 pandemic

机译:英国关于根据 COVID-19 大流行诊断诱发性喉梗阻的共识声明

获取原文
获取原文并翻译 | 示例

摘要

Abstract Prior to the COVID‐19 pandemic, laryngoscopy was the mandatory gold standard for the accurate assessment and diagnosis of inducible laryngeal obstruction. However, upper airway endoscopy is considered an aerosol‐generating procedure in professional guidelines, meaning routine procedures are highly challenging and the availability of laryngoscopy is reduced. In response, we have convened a multidisciplinary panel with broad experience in managing this disease and agreed a recommended strategy for presumptive diagnosis in patients who cannot have laryngoscopy performed due to pandemic restrictions. To maintain clinical standards whilst ensuring patient safety, we discuss the importance of triage, information gathering, symptom assessment and early review of response to treatment. The consensus recommendations will also be potentially relevant to other future situations where access to laryngoscopy is restricted, although we emphasize that this investigation remains the gold standard.
机译:摘要 在 COVID-19 大流行之前,喉镜检查是准确评估和诊断诱发性喉梗阻的强制性金标准。然而,在专业指南中,上气道内窥镜检查被认为是一种产生气溶胶的手术,这意味着常规手术极具挑战性,喉镜检查的可用性降低。作为回应,我们召集了一个在管理这种疾病方面具有丰富经验的多学科小组,并就因大流行限制而无法进行喉镜检查的患者的推定诊断策略达成了建议。为了在确保患者安全的同时保持临床标准,我们讨论了分诊、信息收集、症状评估和早期审查治疗反应的重要性。共识建议也可能与未来喉镜检查受限的其他情况相关,尽管我们强调这项调查仍然是黄金标准。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号